This indicates that NSC23766 either exhibits RAC1-independent off-target effects or that RAC1 activation due to alternative upstream regulators also plays a role in non-subgroup-2 HCC and in normal hepatocytes. Here, RAC1 is linked to hepatocellular carcinoma.